NFKB1 and obesity disorder: Celastrol treatment reduced body weight in obese mice in accordance with the report of Liu et al. [24] who demonstrated its anti-obesity action via increasing leptin sensitivity to hypothalamus and improving insulin sensitivity by inhibiting the NF-κB pathway.